Articles

Kuala Lumpur, May 20, 2019 – Duopharma Biotech Berhad’s (Duopharma Biotech) (formerly known as CCM Duopharma Biotech Berhad) first quarter Profit before tax (PBT) rose 41.73 per cent to RM18.79 million for the period ending March 31, 2019 from RM13.26 million in the corresponding period ended March 31, 2018 on the back of higher demand from the private and public health sector.

Kuala Lumpur, April 29, 2019- Efforts to encourage and unearth more budding talents to take up tennis with the hope of representing the nation in the future, were given a shot in the arm recently when CHAMPS®, Malaysia’s leading children health supplement brand, pledged RM50,000 for the organising of the First Serve Tennis Malaysia Kid’s Grand Prix 2019.

Batang Kali, April 14, 2019 – Duopharma Biotech Berhad (“Duopharma Biotech”) has contributed RM60,000.00 to the Angkat 1.0 Programme organised by the Academia-Industry Talent Exchange program (“AIxCHANGE”): CEO @Faculty Program 2.0 Cycle 2 and EPIC Homes (“Extraordinary People Impacting Community”), a non-governmental organisation (“NGO”) which has been active in facilitating the development and enabling community-based housing solutions for Orang Asli community.

Kajang, March 19, 2019 – More than 90 cancer patients, caregivers, healthcare professionals and members of the
public congregated at a golf resort here recently to attend the annual Lavender Ribbon Campaign
and renew their pledge in fighting against cancer, whilst getting first-hand information on the latest
medication and ways to prevent and reduce the risk of the disease.

PUTRAJAYA, 21 March 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) is committed to provide on-the-job training placements for graduates under the government’s Professional Training and Education for Growing Entrepreneurs (PROTÉGÉ) programme.

Shah Alam – CCM Duopharma Biotech Berhad (“CCM Duopharma” or “the Company”) has unveiled its new corporate identity in line with its corporate rebranding exercise. The Company is now undergoing its rebranding exercise following the demerger from its then parent company, Chemical Company of Malaysia Berhad (“CCM Berhad”) in December 2017.

CCM Duopharma Biotech Berhad (CCM Duopharma) has recorded an improved Profit before Tax (PBT) of RM59.67 million for the financial year ended December 31, 2018 (FY2018), an increase of 15.25 per cent as compared to RM51.77 million in the corresponding period in 2017.

Kuala Lumpur, January 22, 2019 – CCM Duopharma Biotech Berhad (CCM Duopharma) in collaboration with the Polis Traffic Investigation and Enforcement Department (JSPT) of Royal Malaysia Police
(PDRM) launched the motorcycle road safety campaign which aims to educate and generate
greater awareness on the importance of road safety amongst motorcyclists especially during
the upcoming Chinese New Year celebration and the Hari Raya Aildilfitri festivity mid this
year.

Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) grew its Revenue by 7.69 per cent to RM383.09 million from RM355.73 million for the first nine months of its financial year ended September 30, 2018. The Company’s Profit Before Tax (PBT) for the period under review rose 7.80 per cent to RM42.01 million from RM38.97 million.

Kuala Lumpur November 27, 2018 – High quality, internationally proven biosimilar diabetic therapy that is cost effective can effectively substitute ‘branded’ innovator drugs in reducing the burden on public health and paying patients to manage the cost of treating diabetes in Malaysia, which has the highest number of diabetics in the Asean region.